Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

98 results found in London, UK

Sort by:
Showing 91 - 98 of 98 results
Expert in: Oncology
Clinical Oncology

Dr Omar Al-Salihi is a Neuro-oncologist and Consultant Clinical Oncologist at Guy’s and St Thomas Hospital specialising in the Neuro-oncology of high-grade and low-grade gliomas and the use of Radiotherapy for the treatment soft tissue sarcomas.

Dr Al-Salihi was previously a Principal Investigator and core member of the adult brain tumors MDT at Southampton in the period of 2008-2018.

Read more
Expert in: Oncology
45 years of experience

Professor Angus Dalgleish studied medicine at University College London where he obtained an MBBS and a BSc in Anatomy. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists. After graduating and house jobs in London and Poole, he spent a year in the flying doctor service in Queensland. He also trained in Internal Medicine and Oncology in Brisbane and Sydney. Having developed an interest in how viruses caused cancer, he commenced an MD with Professor Robin Weiss, FRS at the Institute of Cancer Research and Royal Marsden Hospital.

Following five years as a clinical scientist at the MRC's clinical research centre in Northwick Park, Professor Dalgleish was appointed to the Foundation Chair in Oncology at the St George's University of London in 1991. There his main interest has been the immunology of cancer and the development of immunotherapies to treat, in particular, melanoma. He is a co-founder of Onyvax, a company set up in 1998 to make novel vaccines for common solid tumours, where he is currently Research Director.

Professor Dalgleish currently sits on eight editorial boards and is the author or co-author of peer-reviewed scientific papers and over 70 chapters in medical books. He is the co-editor of five medical books and has been on numerous grant committees and is currently on the European Commission Cancer Board.

Read more
Expert in: Oncology
32 years of experience

Hani Gabra is Professor of Medical Oncology at Imperial College London, based at its Hammersmith Campus. His clinical work in conducted at a number of sites including the Hammersmith Hospital and the Queen Charlotte Hospital for Women. He specialises in gynaecological and upper gastrointestinal cancers.

After studying medicine at the University of Glasgow, he completed his MSc in Clinical Oncology and a PhD in Molecular Oncology at the University of Edinburgh. He then went on to complete specialist training in Cancer Medicine and was a Clinical Scientist and Consultant Medical Oncologist at the CRUK Edinburgh Medical Oncology Unit from 1998-2003. He then moved to London to take up his post at Imperial College.

Professor Gabra is actively involved in clinical research in ovarian cancer and tumour suppressor genes. He is Director of the Ovarian Cancer Action (HHMT) research Unit, a core funded research unit based at Imperial College London. He is also Chief of Service of the West London Gynaecological Cancer Centre and Head of the Section of Molecular Therapeutics in the Department of Oncology at Imperial College.  

Read more
Expert in: Oncology
43 years of experience

Professor Jonathan Waxman trained at University College and University College Hospital, London, in common with a number of other consultants practising at LOC. He was the recipient of several scholarships and prizes as an undergraduate and postgraduate. He is currently Professor of Oncology at Imperial College London and consultant to the Department of Oncology at Hammersmith Hospital, for whom he played the central role in the campaign to build the Hammersmith Cancer Centre.

He founded the Prostate Cancer Charity which will raise £20m in this current financial year. Prior to joining the Hammersmith Hospital, he was an Imperial Cancer Research Fund Research Fellow at St Bartholomew’s Hospital.

His current clinical and laboratory research focus is prostate cancer. He has written over 400 research papers and book chapters, has authored eleven medical books, one novel, a patient information book and a legal text book. He writes on healthcare policy for major newspapers.

Read more
Dr Ajay Mehta

Dr Ajay Mehta

1.25 miles

Dr Ajay Mehta

1.25 miles
Expert in: Oncology
27 years of experience

Dr Ajay Mehta qualified from Guy's Hospital Medical School in 1992. He trained in Oncology at St Bartholemew's, Hammersmith, Mount Vernon and the Royal Marsden Hospitals. He has been a Consultant in Clinical Oncology since 2004 and is currently practising at the Royal Surrey County Hospital in Guildford where he is also the Lead Clinician for Radiotherapy.

He offers comprehensive management of Lung and Upper GI cancers( oesophagus and stomach). This involves systemic therapies such as immunotherapy, targeted therapy and chemotherapy. He also has expertise in advanced radiotherapy techniques such as IMRT, RapidARC and SABR. He is the principal investigator for several clinical trials. He is an examiner for the Royal College of Radiologists and the GMC. He has a BSc in Experimental Pathology and a Diploma in Medical Ethics

Read more
Expert in: General Medicine
37 years of experience
Medical Oncology

Dr David Propper is a Consultant Medical Oncologist based at Barts and The London NHS Trust, with specialist interests in Breast, Colorectal (Large Bowel), Hepatobiliary, Oesophagus & Stomach oncology. Dr Propper also has interests in translational research, early phase trials and the introduction of new therapeutic agents, and outside his clincal work, he continues his commitment as a consultant and senior lecturer in GI Oncology at St Bartholomew's Hospital in London.

Dr Propper trained in medical oncology at the Imperial Cancer Research Fund Medical Oncology Unit in Oxford, receiving major trial research experience and subsequently spending time at the Lombardi Cancer Centre Georgetown Washington DC, USA.  

Read more
Expert in: Oncology
25 years of experience

Dr Peter Szlosarek is a Clinical Senior Lecturer and Consultant in Medical Oncology at the Barts Cancer Institute (QMUL) and St. Bartholomew’s Hospital.

Peter Szlosarek trained in London teaching hospitals and was awarded a PhD degree in translational cancer medicine from the University of London. Szlosarek's post-doctoral work is focused on the role of the abnormal, his main clinical interests are in melanoma, lung cancer and mesothelioma, with a particular emphasis on targeted drugs and metabolic and immunotherapeutic approaches. 

Read more
Expert in: Oncology
15 years of experience
Clinical Oncology

Dr Gemma Eminowicz is a Consultant Clinical Oncologist based in London. She specialises in the treatment of gynaecological cancers (cervical, endometrial, vulval and vaginal) and the delivery of brachytherapy. She also has a clinical interest in complex targeted radiotherapy delivery using image guidance and adaptive techniques as well as the use of imaging biomarkers during chemo-radiotherapy.

After completing her degree in Medicine at the University of Birmingham in 2004, she undertook specialist training in Oncology and attained a Fellowship with the Royal College of Radiologists in 2011. She was awarded MD(Res) from University College London (UCL) in 2016 for her work on optimisation of cervical cancer radiotherapy. Following this she was appointed a Substantive Consultant and Brachytherapy Lead initially at Imperial College Healthcare Trust. She then moved University College London Hospital, where she is still based.

Alongside her clinical work, Dr Eminowicz is actively involved in oncology research and has worked on a number of international clinical trials. She also is undertaking a study investigating the role of PET-MRI in patients undergoing chemoradiation for cervical cancer. She has presented her work at international both national and international meetings, and has also been published in a number of key oncology journals and book chapters. Dr Eminowicz is an Honorary Clinical Senior Lecturer at UCL and a member of the NCRI Gynaecological Oncology CSG. 

Read more